Article
Absence of deleterious palladin mutations in patients with familial pancreatic cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Apr 2009
Klein Alison P, Borges Michael, Griffith Margaret, Brune Kieran, Hong Seung-Mo, Omura Noriyuki, Hruban Ralph H, Goggins Michael
Abstract excerpt
It has been reported that germline mutations in the palladin gene (PALLD) cause the familial aggregation of pancreatic cancer, but the evidence is weak and controversial. We sequenced the coding regions of PALLD in 48 individuals with familial pancreatic cancer. We did not find any deleterious mu...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.